Biogen
BIIB
NASDAQ
IPO1991
about BIIB
Biogen is a biotechnology company specializing in the development of innovative pharmaceutical treatments for various medical conditions, with a focus on neurology and immunology.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $143.00 | $143.45 | $139.54 | $20.72B | 1.28M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| +$4.33 | 11.44 | 8.01 | 28.12% | 24.00% | 0% |